Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

0.2920

-0.0233 (-7.39%)

At close: Apr 1, 2025, 4:00 PM

0.3026

+0.0106 (3.63%)

After-hours: Apr 1, 2025, 5:05 PM EDT

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $13.46 million as of April 1, 2025. Its market cap has decreased by -67.58% in one year.

Market Cap

13.46M

Enterprise Value

-8.27M

1-Year Change

-67.58%

Ranking

#4930

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $13.46M, an increase of 79.40%. That is a compound annual growth rate of 3.06%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	14.50M	17.89%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	10.38%
Dec 31, 2013	21.20M	-38.19%
Dec 31, 2012	34.30M	190.68%
Dec 30, 2011	11.80M	247.06%
Dec 31, 2010	3.40M	-97.92%
Dec 31, 2009	163.20M	1,484.47%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	732.62B
UnitedHealth Group	478.34B
Johnson & Johnson	398.91B
AbbVie	368.81B
Novo Nordisk	305.46B
Abbott Laboratories	228.69B
AstraZeneca	225.46B
Merck & Co.	224.93B

Market Cap Rankings